PRELUDE CAPITAL MANAGEMENT, LLC - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BIONTECH SE
ValueSharesWeighting
Q2 2022$526,000
-14.9%
3,525
-2.8%
0.02%
-16.7%
Q1 2022$618,000
-33.9%
3,625
-0.1%
0.02%
-25.0%
Q4 2021$935,000
-47.6%
3,628
-44.5%
0.02%
-46.7%
Q3 2021$1,783,000
+67.7%
6,532
+37.5%
0.04%
+40.6%
Q2 2021$1,063,000
+190.4%
4,750
+41.8%
0.03%
+255.6%
Q1 2021$366,000
+8.3%
3,350
-19.3%
0.01%0.0%
Q4 2020$338,000
+17.8%
4,1500.0%0.01%
-35.7%
Q3 2020$287,000
+135.2%
4,150
+126.4%
0.01%
+100.0%
Q2 2020$122,0001,8330.01%
Other shareholders
BIONTECH SE shareholders Q2 2021
NameSharesValueWeighting ↓
Fosun International Ltd 1,053,640$179,709,00015.52%
Bill & Melinda Gates Foundation 148,674$25,400,00013.66%
Baader Bank Aktiengesellschaft 224,800$38,342,0003.07%
Quinn Opportunity Partners LLC 402,239$68,606,0002.96%
Pendal Group Ltd 1,957,594$333,887,0002.75%
Boston Common Asset Management, LLC 280,181$47,788,0002.06%
Tri Locum Partners LP 30,923$5,274,0002.06%
Renaissance Capital LLC 25,267$4,310,0001.83%
Robbins Farley 13,220$2,255,0001.70%
APEIRON CAPITAL Ltd 21,300$3,633,0001.61%
View complete list of BIONTECH SE shareholders